BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2453008)

  • 21. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic loculated malignant pleural effusion treatment with indwelling Tenckhoff catheter.
    Hussain SA; Burton GM; Yuce M
    Chest; 1990 Mar; 97(3):766-7. PubMed ID: 2155090
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of malignant pleural effusion.
    Reshad K; Inui K; Takeuchi Y; Takahashi Y; Hitomi S
    Chest; 1985 Sep; 88(3):393-7. PubMed ID: 2411478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endocavitary beta-interferon in neoplastic effusions.
    Cherchi PL; Campiglio A; Rubattu A; Desole A; Andria G; Ambrosini A
    Eur J Gynaecol Oncol; 1990; 11(6):477-9. PubMed ID: 2086232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodized talc pleurodesis for the treatment of pleural effusions.
    Webb WR; Ozmen V; Moulder PV; Shabahang B; Breaux J
    J Thorac Cardiovasc Surg; 1992 May; 103(5):881-5; discussion 885-6. PubMed ID: 1569770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomized trial of intrapleural bleomycin versus interferon alfa-2b via ultrasound-guided small-bore chest tube in the palliative treatment of malignant pleural effusions.
    Sartori S; Tassinari D; Ceccotti P; Tombesi P; Nielsen I; Trevisani L; Abbasciano V
    J Clin Oncol; 2004 Apr; 22(7):1228-33. PubMed ID: 15051770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
    Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
    Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intrapleural transfer of LAK cells combined with rIL-2 in the treatment of advanced lung cancer with malignant pleural effusion].
    Li DJ
    Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):294-6. PubMed ID: 2625114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pleuroperitoneal shunt for recurrent malignant pleural effusions.
    Tsang V; Fernando HC; Goldstraw P
    Thorax; 1990 May; 45(5):369-72. PubMed ID: 1696401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombocytosis in patients with malignant pleural mesothelioma.
    Nakano T; Fujii J; Tamura S; Hada T; Higashino K
    Cancer; 1986 Oct; 58(8):1699-701. PubMed ID: 3019510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality treatment including parietal pleurectomy as a possible therapeutic procedure for malignant pleural effusion.
    Ohta Y; Oda M; Shimizu J; Watanabe G
    Surg Technol Int; 2007; 16():184-9. PubMed ID: 17429787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intracavitary administration of recombinant interferon in cancer patients with malignant effusions].
    Takashima S; Saeki T; Saeki H; Tanada M; Takiyama W; Kimura T; Moriwaki S
    Gan No Rinsho; 1986 Sep; 32(11):1451-7. PubMed ID: 3773273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliation in malignant pleural effusion.
    Johnson LP; Rivkin SE; Weber EL
    Am Surg; 1975 Sep; 41(9):529-34. PubMed ID: 52306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignant pleural effusions and their treatment by intercostal talc pleurodesis.
    Harley HR
    Br J Dis Chest; 1979 Apr; 73(2):173-7. PubMed ID: 534605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intrapleural recombinant interleukin-2 in immunotherapy for malignant pleural effusion.
    Astoul P; Bertault-Peres P; Durand A; Catalin J; Vignal F; Boutin C
    Cancer; 1994 Jan; 73(2):308-13. PubMed ID: 8293393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human leukocyte interferon alpha (HLI-alpha) for treatment of pleural effusion caused by non small cell lung cancer. A pilot study.
    Tercelj-Zorman M; Mermolja M; Jereb M; Oman M; Soos E; Petric-Grabnar G; Jereb B
    Acta Oncol; 1991; 30(8):963-5. PubMed ID: 1663775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of malignant pleural effusions with intrapleural Corynebacterium parvum or tetracycline.
    Leahy BC; Honeybourne D; Brear SG; Carroll KB; Thatcher N; Stretton TB
    Eur J Respir Dis; 1985 Jan; 66(1):50-4. PubMed ID: 3979476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Palliative treatment of malignant pleural effusions with intrapleural injection of colloidal radioactive gold].
    FAUVET J; COURT P; DUTREIX J; PIERQUIN B; TUBIANA M
    J Fr Med Chir Thorac; 1956; 10(1):100-12; discussion, 112-3. PubMed ID: 13332209
    [No Abstract]   [Full Text] [Related]  

  • 39. [Aclacinomycin; benefits for the treatment of malignant pleural effusion].
    Homma T; Min KY; Yoneda S; Yoshida S; Nakagawa H
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1810-6. PubMed ID: 6309098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nursing care of patients treated with intrapleural tetracycline for control of malignant pleural effusion.
    Rossetti AC
    Cancer Nurs; 1985 Apr; 8(2):103-9. PubMed ID: 3846482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.